{"id":1938,"date":"2013-06-14T13:53:57","date_gmt":"2013-06-14T12:53:57","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=1938"},"modified":"2013-06-14T13:53:57","modified_gmt":"2013-06-14T12:53:57","slug":"farmacs-antineoplasics-orals","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2013\/06\/14\/farmacs-antineoplasics-orals\/","title":{"rendered":"F\u00e1rmacos antineopl\u00e1sicos orales"},"content":{"rendered":"<p>Esta actividad, organizada por la Sociedad Catalana de Farmacia Cl\u00ednica (SCFC) y el Colegio, tuvo lugar el 28 de mayo en la sede colegial con el patrocinio de Novartis. La formaci\u00f3n iba dirigida a <strong>farmac\u00e9uticos de hospitales y de centros de atenci\u00f3n primaria <\/strong>para ponerlos al d\u00eda de la<strong> farmacoterapia de los antineopl\u00e1sicos orales, las interacciones y la necesaria adherencia al tratamiento y las intervenciones en atenci\u00f3n farmac\u00e9utica y educaci\u00f3n sanitaria<\/strong> requeridas para estos pacientes y medicamentos.<\/p>\n<p>Cada vez son m\u00e1s los f\u00e1rmacos antineopl\u00e1sicos de administraci\u00f3n oral y las expectativas m\u00e1s conservadoras pronostican que durante la pr\u00f3xima d\u00e9cada representar\u00e1n el 25% de todos los agentes antitumorales. Los pacientes prefieren la quimioterapia oral porque les proporciona mayor autonom\u00eda, evita punciones y riesgos asociados a la utilizaci\u00f3n de cat\u00e9teres endovenosos o reservorios en v\u00edas centrales. Sin embargo, los antineopl\u00e1sicos orales son un reto para los profesionales por situaciones nuevas no previstas hasta ahora como la confirmaci\u00f3n de la adherencia al tratamiento, la aparici\u00f3n de efectos adversos generales, nuevos de cada mol\u00e9cula y c\u00f3mo tratarlos, recomendaciones de uso.<\/p>\n<p>En el equipo docente participaron <b>Natalia Creus<\/b>, farmac\u00e9utica adjunta, Hospital Cl\u00ednic de Barcelona; <b>Eduard Fort<\/b>, farmac\u00e9utico adjunto, Instituto Catal\u00e1n Oncolog\u00eda \u2013 Hospital Duran i Reynals; <b>Clara Lezcano<\/b>, farmac\u00e9utica adjunta, Instituto Catal\u00e1n Oncolog\u00eda -Hospital Universitario Germans Trias i Pujol de Badalona; <b>Estela Moreno<\/b> farmac\u00e9utica adjunta, Hospital de la Santa Cruz y San Pablo de Barcelona; <b>Maria Perayre<\/b>, farmac\u00e9utica adjunta, Instituto Catal\u00e1n Oncolog\u00eda \u2013 Hospital Duran i Reynals; <b>N\u00faria Quer<\/b>, farmac\u00e9utica adjunta, Instituto Catal\u00e1n Oncolog\u00eda, Hospital Josep Trueta, y <b>Carolina Valdivia<\/b>, farmac\u00e9utica especialista, Hospital Universitari Vall d&#039;Hebron de Barcelona.<\/p>\n<p>La coordinaci\u00f3n corri\u00f3 a cargo de <b>Tom\u00e1s Casas\u00edn<\/b>, vocal de Hospitales del COF de Barcelona; <b>Eduard Fort,<\/b> farmac\u00e9utico adjunto, Instituto Catal\u00e1n Oncolog\u00eda \u2013 Hospital Duran i Reynals, y <b>Julio Mart\u00ednez<\/b>, presidente de la Sociedad Catalana de Farmacia Cl\u00ednica (SCFC).<\/p>","protected":false},"excerpt":{"rendered":"<p>Esta actividad, organizada por la Sociedad Catalana de Farmacia Cl\u00ednica (SCFC) y el Colegio, tuvo lugar el 28 de mayo en la sede colegial con el patrocinio de Novartis. La formaci\u00f3n iba dirigida a farmac\u00e9uticos de hospitales y centros de atenci\u00f3n primaria para ponerlos al d\u00eda de la farmacoterapia de los [\u2026]<\/p>","protected":false},"author":1,"featured_media":1945,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[70,481],"class_list":["post-1938","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-formacio","tag-hospitals"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>F\u00e0rmacs antineopl\u00e0sics orals - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2013\/06\/14\/farmacs-antineoplasics-orals\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"F\u00e0rmacs antineopl\u00e0sics orals - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"Aquesta activitat, organitzada per la Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC) i el Col\u00b7legi, va tenir lloc el 28 de maig a la seu col\u00b7legial amb el patrocini de Novartis. La formaci\u00f3 anava dirigida a farmac\u00e8utics d\u2019hospitals i de centres d\u2019atenci\u00f3 prim\u00e0ria per posar-los al dia de la farmacoter\u00e0pia dels [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2013\/06\/14\/farmacs-antineoplasics-orals\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2013-06-14T12:53:57+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/06\/14\/farmacs-antineoplasics-orals\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/06\/14\/farmacs-antineoplasics-orals\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"F\u00e0rmacs antineopl\u00e0sics orals\",\"datePublished\":\"2013-06-14T12:53:57+00:00\",\"dateModified\":\"2013-06-14T12:53:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/06\/14\/farmacs-antineoplasics-orals\/\"},\"wordCount\":352,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/06\/14\/farmacs-antineoplasics-orals\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Formaci\u00f3\",\"Hospitals\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2013\/06\/14\/farmacs-antineoplasics-orals\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/06\/14\/farmacs-antineoplasics-orals\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2013\/06\/14\/farmacs-antineoplasics-orals\/\",\"name\":\"F\u00e0rmacs antineopl\u00e0sics orals - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/06\/14\/farmacs-antineoplasics-orals\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/06\/14\/farmacs-antineoplasics-orals\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2013-06-14T12:53:57+00:00\",\"dateModified\":\"2013-06-14T12:53:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/06\/14\/farmacs-antineoplasics-orals\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2013\/06\/14\/farmacs-antineoplasics-orals\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/06\/14\/farmacs-antineoplasics-orals\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/06\/14\/farmacs-antineoplasics-orals\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"F\u00e0rmacs antineopl\u00e0sics orals\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"F\u00e0rmacs antineopl\u00e0sics orals - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2013\/06\/14\/farmacs-antineoplasics-orals\/","og_locale":"es_ES","og_type":"article","og_title":"F\u00e0rmacs antineopl\u00e0sics orals - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"Aquesta activitat, organitzada per la Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC) i el Col\u00b7legi, va tenir lloc el 28 de maig a la seu col\u00b7legial amb el patrocini de Novartis. La formaci\u00f3 anava dirigida a farmac\u00e8utics d\u2019hospitals i de centres d\u2019atenci\u00f3 prim\u00e0ria per posar-los al dia de la farmacoter\u00e0pia dels [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2013\/06\/14\/farmacs-antineoplasics-orals\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2013-06-14T12:53:57+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2013\/06\/14\/farmacs-antineoplasics-orals\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2013\/06\/14\/farmacs-antineoplasics-orals\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"F\u00e0rmacs antineopl\u00e0sics orals","datePublished":"2013-06-14T12:53:57+00:00","dateModified":"2013-06-14T12:53:57+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2013\/06\/14\/farmacs-antineoplasics-orals\/"},"wordCount":352,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2013\/06\/14\/farmacs-antineoplasics-orals\/#primaryimage"},"thumbnailUrl":"","keywords":["Formaci\u00f3","Hospitals"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2013\/06\/14\/farmacs-antineoplasics-orals\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2013\/06\/14\/farmacs-antineoplasics-orals\/","url":"https:\/\/novaorg.cofb.net\/2013\/06\/14\/farmacs-antineoplasics-orals\/","name":"F\u00e0rmacs antineopl\u00e0sics orals - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2013\/06\/14\/farmacs-antineoplasics-orals\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2013\/06\/14\/farmacs-antineoplasics-orals\/#primaryimage"},"thumbnailUrl":"","datePublished":"2013-06-14T12:53:57+00:00","dateModified":"2013-06-14T12:53:57+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2013\/06\/14\/farmacs-antineoplasics-orals\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2013\/06\/14\/farmacs-antineoplasics-orals\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/novaorg.cofb.net\/2013\/06\/14\/farmacs-antineoplasics-orals\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2013\/06\/14\/farmacs-antineoplasics-orals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"F\u00e0rmacs antineopl\u00e0sics orals"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"Aquesta activitat, organitzada per la Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC) i el Col\u00b7legi, va tenir lloc el 28 de maig a la seu col\u00b7legial amb el patrocini de Novartis. La formaci\u00f3 anava dirigida a farmac\u00e8utics d\u2019hospitals i de centres d\u2019atenci\u00f3 prim\u00e0ria per posar-los al dia de la farmacoter\u00e0pia dels [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/1938","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=1938"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/1938\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=1938"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=1938"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=1938"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}